Insulin resistance improvement

Insulin resistance improvement" refers to the outcome of interventions—pharmacological or lifestyle—that enhance the biological response of tissues (primarily muscle, liver, and adipose) to insulin. While insulin acts via the insulin receptor and downstream pathways such as PI3K/AKT and MAPK, 'improving insulin resistance' represents the reversal of defects (e.g., impaired receptor signaling, chronic inflammation, lipid overload) that diminish insulin effectiveness. Multiple drug classes and lifestyle modifications have demonstrated efficacy in ameliorating insulin resistance through diverse mechanisms targeting multiple molecular and physiological pathways, rather than one specific molecular target or receptor[2][3][4][5]. In summary, "insulin resistance improvement" does not correspond to a single molecular entity and should not be used as a target name; it describes a therapeutic or physiological concept encompassing a wide range of molecular targets and signaling pathways involved in insulin action and glucose homeostasis.

Other names

Insulin sensitizationreversal of insulin resistanceimprovement of insulin sensitivity

Activation of insulin receptor signaling (e.g., enhancing INSR, IRS1/2, PI3K/AKT pathways); Suppression of inflammatory signals (e.g., inhibition of TNF-α, JNK, IKKβ pathways); Reduction of ectopic lipid accumulation in liver and muscle; Positive modulation of adipokine secretion; Inhibition of negative regulators (e.g., protein tyrosine phosphatase 1B (PTP1B))